According to a recent study, daily crisaborole ointment was efficiacious in treating mild-to-moderate atopic dermatitits (AD) long-term.
Tildrakizumab efficacious in treating scalp psoriasis
According to a recent study, tildrakizumab was shown to be efficacious in treating moderate-to-severe plaque psoriasis on the scalp.
Topical treatment improves sleep quality in PsO, AD patients
According to a recent study, topical treatment decreases itch and improves sleep patterns in patients with psoriasis and atopic dermatitis.
Study finds link between skin disorder visibility and stigma
According to a recent study, the visibility of a skin disorder is directly linked to stigma including bullying.
Antibiotics in first year of life linked to increased AD risk in infants
According to a recent study, early-life antibiotic use affects the gut microbiome which may lead to an increased risk of atopic dermatitis (AD).
Patients with HS at higher risk of respiratory disease
According to a recent study, hidradenitis suppurativa (HS) patients are at higher risk for respiratory diseases.
Depression, suicidal ideation low in PsO patients on bimekizumab, according to new study
According to a recent study, suicidal ideation and behaviour and depression are low and within general psoriasis ranges in patients being treated with bimekizumab.
New study highlights delays in diagnosis for HS
According to a recent study, there are significant delays in diagnosis and low implementation rates for treatment for hidradenitis suppurativa (HS).
Topical melatonin, rosuvastatin may reduce severity of mild-to-moderate plaque PsO
According to a recent study, topical melatonin and topical rosuvastatin were both effective in reducing the severity of mild-to-moderate plaque psoriasis.
New study shows dupilumab is efficacious, safe in treatment of AD in youth
According to a recent real-world study, dupilumab is safe and efficacious in treating moderate-to-severe atopic dermatitis (AD) in pediatric patients.
HealthMinute.TV 